Literature DB >> 935278

Congenital giant nevi: clinical and pathological considerations.

V C Lanier, K L Pickrell, N G Georgiade.   

Abstract

A clinical and pathological review of 67 cases of congenital giant nevi and of 5 cases of malignant transformation in congenital giant nevi brings out the following. 1. The lesions should be regarded as premalignant. 2. An aggressive approach is advocated to remove the lesion before school age. 3. Staged excisions, combined with skin grafting and/or local rotation flaps, are advocated. 4. Any nodularity or ulceration developing within a congenital giant nevus should be regarded as an ominous sign. 5. A long-term follow-up is necessary in those patients having subtotal excisions.

Entities:  

Mesh:

Year:  1976        PMID: 935278     DOI: 10.1097/00006534-197607000-00008

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  A change in birth mark.

Authors:  Hadi Mirfazaelian; Ahmad Mosalei; Yahya Daneshbod
Journal:  Intern Emerg Med       Date:  2013-02-09       Impact factor: 3.397

2.  Bulky naevocytoma of the perineum: a singular variant of congenital giant pigmented naevus.

Authors:  M Reyes-Mugica; F Gonzalez-Crussi; B S Bauer; G Medina-Escobedo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  A prospective study of patients with large congenital melanocytic nevi and the risk of melanoma.

Authors:  Ana Carolina Leite Viana; Eugênio Marcos Andrade Goulart; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

4.  Giant congenital melanocytic nevus of the scalp: from clinical-histological to molecular diagnosis.

Authors:  Yi Sun; Yun Zou; Lizhen Wang; Hao Gu; Qingqing Cen; Hui Chen; Xiaoxi Lin; Ren Cai
Journal:  Hereditas       Date:  2020-05-19       Impact factor: 3.271

Review 5.  Giant congenital melanocytic nevus.

Authors:  Ana Carolina Leite Viana; Bernardo Gontijo; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.